The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest

Heart Failure

Hypertension

Hypertrophic Cardiomyopathy

Baxrostat

European Society Of Cardiology

American College Of Cardiology

Oceanic Stroke Trial

Sglt-2 Inhibitors

Hypertension Guidelines

Ferric Carboxymaltose

CKM Syndrome

Polypill

Poly-Hf

Inflammation

Cardiac Myosin Inhibitors

PCSK9 Inhibitors

LDL Cholesterol

Amyloid

Factor Xia Inhibition

Zalunfiban

This podcast delivers concise clinical updates in cardiology alongside insightful career stories from pharmacists in the field. Host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, CACP, provides essential knowledge and practical perspectives for pharmacy professionals specializing in cardiovascular care.

11 ratings

Publishes	Twice monthly	Episodes	34	Founded	a year ago
Number of Listeners		Categories	ScienceLife Sciences

Listen to this Podcast

Guests Host Reviews Charts Talking Points

Latest Episodes

33: Craig Beavers, PharmD Breaks Down the 2026 CKM Guidelines — And Why They Matter

In this solo episode of the Tell-Tale Heart podcast, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, delivers an immediate reaction to the newly released 2026 AHA/ACC/ADA/ASN guidelines for cardiovascular kidney metaboli... more

10 Jun 2026 • 12 min • Most popular

32: What's Making Headlines in Cardiovascular Care: A Pharmacist's Breakdown of the Latest Breakthroughs

In this mini news episode of the Tell-Tale Heart podcast, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, highlights three major developments in cardiovascular and cardiometabolic medicine that pharmacists should have on... more

27 May 2026 • 8 min

31: From Misdiagnosis to Advocacy: Addressing Bias and Equity in Heart Failure Management

In this episode of The Tell-Tale Heart, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, speaks with Rhonda Monroe, MBA, a heart failure survivor and lead advocate at HeartLife, about her lived experience with spontaneous... more

12 May 2026 • 53 min

30: Debriefing ACC 2026: Key Cardiovascular Trials and Their Clinical Implications for Pharmacists

In this episode of The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, welcomes back Kyle Fischer, PharmD, BCCP, MBA, a cardiology clinical pharmacy specialist at ... more

28 Apr 2026 • 55 min

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

BreakpointsSociety of Infectious Diseases Pharmacists

NPR News NowNPR

Up First from NPRNPR

The DailyThe New York Times

The Curbsiders Internal Medicine PodcastThe Curbsiders Internal Medicine Podcast

Recent Guests

Rhonda Monroe

Heart failure survivor, advocate for heart patients globally

HeartLife; Women Heart; Boost (Better Outcomes, Optimal Scientific Therapies)

Episode: 31: From Misdiagnosis to Advocacy: Addressing Bias and Equity in Heart Failure Management

Kyle Fisher

Cardiology and Clinical Pharmacy Specialist

Ascension Texas

Episode: 30: Debriefing ACC 2026: Key Cardiovascular Trials and Their Clinical Implications for Pharmacists

Dave Dixon

Professor and Chair of the Department of Pharmacotherapy and Outcome Science at Virginia Commonwealth University

Virginia Commonwealth University

Episode: 29: New Dyslipidemia Guidelines Restore LDL Goals and Expand Pharmacist Opportunities

Kristen Campbell

Clinical pharmacist at Duke University focusing on electrophysiology

Duke University Medical Center

Episode: 27: Pharmacists’ Evolving Role in Electrophysiology Takes Center Stage Ahead of ACC 2026

Allison Burnett

Thrombosis and hemostasis pharmacist at the University of New Mexico Hospital; residency program director for PGY-2 thrombosis and hemostasis

University of New Mexico Hospital

Episode: 28: Unpacking the 2025 ACC/AHA Pulmonary Embolism Guidelines With a Thrombosis Pharmacist

Ambers Fendi

Cardiologist, UT Southwestern Medical Center, Dallas, Texas

UT Southwestern Medical Center

Episode: 25: How the POLY-HF Trial Shows Pharmacists' Key Role in Heart Failure Care

Nick Miller

Compounding pharmacist, Pharmacy Solutions

Pharmacy Solutions

Episode: 25: How the POLY-HF Trial Shows Pharmacists' Key Role in Heart Failure Care

Andrew Williford

Assistant Professor at UC San Diego Skag School of Pharmacy and Pharmaceutical Sciences; clinician managing cardiac myosin inhibitors and HCM patients

UC San Diego Health; UC San Diego Health (clinic)

Episode: 24: Hypertrophic Cardiomyopathy: What Pharmacists Need to Know in 2026

Marc Baines

Co-founder and executive director of HeartLife Canada

HeartLife Canada

Episode: 22: From Diagnosis to Transplant: A Heart Failure Patient’s Journey and the Pharmacists’ Impact Along the Way

Host

Craig Beavers

Host of cardiovascular pharmacotherapy updates and practitioner-focused discussions.

Reviews

4.9 out of 5 stars from 11 ratings

Keep it up!
Every episode has been worth listening to! Insightful topics and expert guests!
Apple Podcasts
5
Jpluenneke
United States9 months ago
Big fan already!
Informative and entertaining. I’m excited to see what else Craig has in store.
Apple Podcasts
5
Baker0621
United Statesa year ago
Can’t wait!!!
I am so excited for this!
Apple Podcasts
4
thisnicknameistakenalso
United Statesa year ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners value the concise, clinically grounded updates.

Guests come from diverse pharmacy and academic backgrounds.

Show framing helps sponsors understand practical impact on practice.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts	#135	United States/Science/Life Sciences
Apple Podcasts	#28	Taiwan/Science/Life Sciences
Apple Podcasts	#52	Saudi Arabia/Science/Life Sciences
Apple Podcasts	#66	Philippines/Science/Life Sciences
Apple Podcasts	#142	Israel/Science/Life Sciences
Apple Podcasts	#223	Taiwan/Science

Talking Points

Recent interactions between the hosts and their guests.

15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials

Q: How do these trials influence guideline-concordant practice and anticoagulation stewardship?

They reinforce the idea that stopping antiplatelets after 12 months in high-risk patients on DOACs can be appropriate, while maintaining anticoagulation in patients with ongoing risk, and they highlight the need for careful patient selection and monitoring to prevent adverse outcomes when de-escalating therapy.

15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials

Q: What did AQUATIC add to our understanding of antithrombotic therapy after PCI and AFib?

AQUATIC was a double-blind trial in a higher-risk population comparing DOAC monotherapy to DOAC plus antiplatelet therapy, showing a significant primary efficacy advantage for monotherapy with respect to ischemic and bleeding outcomes, suggesting that in selected high-risk patients, aspirin may be unnecessary beyond a certain post-PCI period.

15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials

Q: Tell us about Lone AF trial background and what it sought to answer.

The Lone AF trial enrolled patients who had undergone catheter ablation at least 12 months earlier and remained in sinus rhythm, randomizing them to continue versus discontinue anticoagulation; it was open-label and powered to detect differences in the primary endpoint, which was driven largely by bleeding events given the low overall event rate.

11: A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Q: Robert Page, how do you foresee the Victor versus Victoria data shaping our understanding of vericiguat-like therapies in HF patients?

Robert explains that Victor aims to include more NYHA Class II patients and a broader African American representation, which could reveal differential benefits. He cautions that outcomes may hinge on baseline GDMT use and whether the added therapy meaningfully reduces hospitalization or mortality in a real-world, highly treated population.

11: A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Q: Kaitlin, what are your thoughts on the two beta-blocker post-MI trials and their potential to influence practice after ESC?

Kaitlin notes that both reboot and Beta MI Dan Block mirror Reduce AMI's focus, but emphasize contemporary GDMT contexts, differing in timing and revascularization requirements. She expects results to clarify optimal beta-blocker selection and dosing in modern post-MI patients with preserved EF, while highlighting that adoption in practice will depend on subgroup findings and real-world applicability.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

Concise clinical updates in cardiovascular pharmacotherapy paired with practitioner-focused career stories from pharmacists. Episodes frequently cover trial results, guideline implications, and practical workflows for pharmacy teams, with guests ranging from academic lipid and anticoagulation experts to EP pharmacists and patient-advocacy voices. Notable strengths include a clinician-first lens on translating research into practice, a strong emphasis on multidisciplinary care, and interactive previews of major cardiology meetings. This show is likely to appeal to pharmacists and clinicians who want actionable insights, real-world implementations, and a clear view of how emerging data shapes patient care and pharmacy practice.

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. Breakpoints
2. NPR News Now
3. Up First from NPR
4. The Daily
5. The Curbsiders Internal Medicine Podcast

How many episodes of this podcast are there?

this podcast launched a year ago and published 34 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Rhonda Monroe
2. Kyle Fisher
3. Dave Dixon
4. Kristen Campbell
5. Allison Burnett
6. Ambers Fendi
7. Nick Miller
8. Andrew Williford

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days